INTRODUCTION
============

The middle cerebral artery (MCA) is the most commonly affected artery in ischemic stroke.[@B1][@B2][@B3] The MCA territory can be divided into the superficial MCA territory and lenticulostriate artery (LSA) territory.[@B4] Patients with superficial MCA territory infarction often develop devastating or fatal stroke.[@B5][@B6]

Patients with superficial MCA territory infarction may show concomitant involvement of the LSA territory. The LSA commonly originates from the proximal segment (M1) of the MCA trunk or the superior division of the MCA.[@B7] Thus, the presence of concomitant LSA territory involvement in patients with superficial MCA territory infarction provides information on the relevant artery of infarction, useful for the determination of stroke mechanisms.[@B8][@B9] In addition, co-existing LSA involvement in patients with superficial MCA territory infarction may suggest 1) occlusion of the MCA by larger thrombi, which may result in larger MCA territorial infarctions; 2) more frequent involvement of the adjacent corticospinal tract, which can result in more severe or frequent motor weakness; and 3) a higher risk of brain herniation, because of deeply located sizable infarctions. All these factors may affect patient outcomes. Furthermore, stroke mechanisms may differ in patients with superficial MCA territory infarction, depending on the presence or absence of co-existing LSA territory infarction.

In the present study, we compared the mechanisms thereof, severities of stroke, and long-term outcomes in patients with the superficial MCA territory infarction in relation to the presence or absence of LSA involvement.

MATERIALS AND METHODS
=====================

Study population and group
--------------------------

This was a retrospective observational study using a prospectively registered cohort data.[@B10] The present study included patients admitted between January 2010 and December 2012 with first-ever infarction involving the unilateral MCA superficial territory within 7 days of symptom onset. Patients who had co-exiting infarctions in other territories were excluded. The patients were evaluated using standardized protocols, including brain computed tomography (CT), magnetic resonance imaging with diffusion-weighted imaging (DWI), and cerebral angiographic studies, such as MR angiography, CT angiography, and digital subtraction angiography. Cardiac evaluation included transesophageal echocardiography (TEE), transthoracic echocardiography (TTE), heart CT scan, and Holter or con-tinuous electrocardiography monitoring during patient stay in the stroke unit. The patients were managed using standardized protocols of our stroke center based on given guidelines.[@B11][@B12]

We divided the patients with superficial MCA territory infarction into two groups according to the presence of concomitant LSA territory infarction: the superficial MCA only (SM) group and the superficial MCA plus LSA (SM+L) group. The Institutional Review Board of Severance Hospital, Yonsei University Health System approved this study and waived the need for informed consent, owing to the retrospective and observational nature of the study.

Definition of risk factors
--------------------------

Hypertension was defined as blood pressure recordings of systolic ≥140 mm Hg or diastolic ≥90 mm Hg on repeated measurements during hospitalization or being on antihypertensive medication. Diabetes mellitus was diagnosed based on a fasting plasma glucose level ≥7 mmol/L, a glycated hemoglobin value ≥6.5%, or when patients had been treated with oral hypoglycemic agents or insulin. Hypercholesterolemia was defined as a fasting serum total cholesterol level ≥6.2 mmol/L, low-density lipoprotein-cholesterol \>4.1 mmol/L, or being treated with lipid lowering agents after a diagnosis of hypercholesterolemia. Patients were regarded as current smokers if they smoked within 1 year prior to admission.

Mechanism of stroke
-------------------

The mechanism of stroke was determined based on the Trial of Org 10172 in the Acute Stroke Treatment (TOAST) classification.[@B13] This study included patients with cardioembolism, large artery atherosclerosis, or stroke of undetermined etiology due to two or more identified causes or due to negative evaluation. Patients with other determined etiologies were excluded from the study. Significant stenosis of the MCA or internal carotid artery (ICA) was defined as stenosis \>50% or occlusion of the artery relevant to the infarction. We identified high-risk potential cardiac source of embolism (PCSE) based on the TOAST classification. The stroke subtype and the degree of arterial stenosis were discussed during weekly stroke conferences and determined in consensus among stroke specialists. These data were registered in the prospective registry.

Infarction volume
-----------------

The volume of infarction was measured on DWI in a semi-automatic manner using Xelis software (Infinitt, Seoul, Korea). An investigator (EHK) who was blinded to the clinical information measured the infarction volumes for the superficial MCA territory and those for the LSA territory. The infarction volume of the superficial MCA territory was compared between the groups.

Stroke severity and long-term outcomes
--------------------------------------

Stroke severity was determined on the basis of National Institute of Health Stroke Scale (NIHSS) at admission. Significant brain swelling was defined as brain edema that required osmotherapy or hemicraniectomy. Poor functional outcome was defined as a modified Rankin Scale (mRS) score \>2 at 3 months after stroke onset. Long-term mortality and causes of death were identified by using death certificates from the Korean National Statistical Office, by reviewing medical records, and by conducting face-to-face or telephone interviews with a research nurse or stroke specialist. Mortality data from the Korean National Statistical Office are considered reliable, since they are collected on the basis of a unique 13-digit identification code assigned to subjects at birth and on the death certificate.[@B14] The cause of death was coded according to the International Classification of Disease (ICD), 10th revision. Stroke mortality was defined by the ICD code as I60--I69. Patients who were alive on August 31, 2014 were censored.

Statistical analyses
--------------------

All statistical analyses were performed using SPSS software for Windows (version 20.0; SPSS Inc., Chicago, IL, USA). The Pearson χ^2^ test was used to compare the frequency of categorical variables. The independent t-test was used to compare continuous variables. The variables achieving *p*-values less than 0.05 in the univariate analyses were entered for multivariate analyses using the logistic regression model to determine the factors associated with poor functional outcome. With regard to long-term mortality, Kaplan-Meier analysis was used to estimate survival, and the log-rank test was used to compare rate estimates. We tested the proportional-hazards assumption by including an interaction term between variables and natural log-transformed follow-up time. Also, we checked log-minus-log survival plots. All variables met a proportional-hazards assumption. Cox proportional hazard regression analysis was performed to calculate crude and adjusted hazard ratios (HR) with 95% confidence intervals (CI). All statistical analyses were two-tailed, and *p*\<0.05 was considered statistically significant.

RESULTS
=======

Demographic and clinical characteristics of the patients
--------------------------------------------------------

During the study period, 1754 consecutive patients were registered to the prospective cohort. At first, 885 patients were excluded because they did not have any infarction in the superficial MCA territory. After excluding 180 patients with co-existing infarctions in other territories or bilateral superficial MCA territories, 689 patients had unilateral infarction involving the superficial MCA territory. Of the 689 patients, we excluded 291 patients who received thrombolytic treatment, had a history of previous cerebral infarction, had other determined etiology based on the TOAST classification, or did not undergo DWI or cerebral angiography. Finally, 398 patients were included in this study ([Supplementary Fig. 1](#S1){ref-type="supplementary-material"}, only online).

Of the 398 patients with superficial MCA territory infarction, the mean age was 66.9±11.7 years and 273 (68.6%) were men. Of the 398 patients, 369 (92.7%) underwent at least one cardiac evaluation (heart CT in 278, TEE in 245, and TTE in 197), and 295 patients (74.1%) were evaluated using continuous electrocardiography monitoring for at least 24 hours. Eighty-four patients (21.1%) had concomitant lesions in the LSA territory (SM+L group). The SM+L group showed higher levels of white blood cells than the SM group. The other demographic characteristics were not different between the groups ([Table 1](#T1){ref-type="table"}).

Mechanism of infarction
-----------------------

Stroke subtypes were different between the groups. Large artery atherosclerosis and two or more causes were more common in the SM+L group. Negative evaluation was more frequent in the SM group (20.1%) than in the SM+L group (4.8%). Compared with the SM group, the SM+L group more commonly had significant stenosis of the MCA or ICA relevant to an infarction and high-risk PCSE ([Table 2](#T2){ref-type="table"}).

Initial stroke severity and infarct volumes
-------------------------------------------

Initial neurologic deficits were more severe in the SM+L group than in the SM group (mean NIHSS, 10.83±7.11 vs. 4.02±4.97, *p*\<0.001) ([Table 1](#T1){ref-type="table"}). We compared the scores of each NIHSS item between the groups to determine whether the higher NIHSS score in the SM+L group was due to symptoms related with LSA lesions, such as weakness, dysarthria, and sensory changes. In doing so, scores for all NIHSS items, except those for ataxia, were significantly higher in the SM+L group ([Fig. 1](#F1){ref-type="fig"}). The infarct volume of the superficial MCA territory was larger in the SM+L group than in the SM group (40.8±62.6 cm^3^ vs. 10.8±21.8 cm^3^, *p*\<0.001) ([Supplementary Fig. 2](#S2){ref-type="supplementary-material"}, only online). Significant brain swelling was also more frequent in the SM+L group (15.5% vs. 3.2%, *p*\<0.001) ([Table 1](#T1){ref-type="table"}).

Long-term outcomes
------------------

Poor functional outcome (mRS\>2) at 3 months was more common in the SM+L group than in the SM group (64.3% vs. 15.9%, *p*\<0.001) ([Fig. 2](#F2){ref-type="fig"}). Univariate analysis showed that the patients with poor functional outcome were less commonly men, were more commonly older age, and had more commonly LSA involvement, current smoking history, higher initial NIHSS score, significant brain swelling, significant MCA stenosis, significant ICA stenosis, high-risk PCSE, and higher white blood cell count, ESR, hsCRP and total cholesterol levels ([Table 3](#T3){ref-type="table"}). Multivariate logistic regression analysis showed that LSA involvement was an independent predictor of poor functional outcome (adjusted odds ratio 3.686, 95% CI 1.693--8.027, *p*= 0.001), along with age, initial NIHSS, significant stenosis of the MCA or ICA relevant to an infarction, and the infarct volume of the superficial MCA territory ([Table 4](#T4){ref-type="table"}).

During a follow-up of mean 26±15 months, 67 patients (16.8%) died. Eighteen patients (4.5%) died of stroke. The SM+L group showed significantly higher all-cause mortality (HR, 2.246; 95% CI, 1.339--3.768) ([Fig. 3A](#F3){ref-type="fig"}) and stroke mortality (HR, 9.193; 95% CI, 3.442--24.556) ([Fig. 3B](#F3){ref-type="fig"}) than the SM group. Multivariate Cox regression analysis, after adjusting factors that were significant on univariate Cox regression analysis ([Supplementary Table 1](#S3){ref-type="supplementary-material"}, only online), showed that LSA involvement was independently associated with long-term stroke mortality along with age, higher initial NIHSS, significant brain swelling, and significant stenosis of the MCA trunk ([Table 5](#T5){ref-type="table"}). Meanwhile, however, multivariate Cox regression analysis ([Supplementary Table 2](#S4){ref-type="supplementary-material"}, only online), revealed that LSA involvement was not independently associated with all-cause mortality.

DISCUSSION
==========

In the present study, we investigated whether initial stroke severity, stroke mechanism, and long-term outcomes differed among patients with superficial MCA territory infarction according to the presence or absence of co-existing LSA territory infarction. We found that initial neurologic deficits were more severe in patients with SM+L group than in those with SM alone. LSA involvement can cause weakness, sensory changes, or dysarthria,[@B15][@B16] and these symptoms might have contributed to the severe neurologic deficits in the SM+L group. However, when baseline NIHSS scores for each item were compared between the groups, all of the items except for ataxia showed higher scores in the SM+L group. These results suggest that the severe neurologic deficits in SM+L patients may be attributed to the wider hemispheric dysfunction, not simply the consequence of the additional LSA territory infarction. Consistent with this hypothesis, the infarction volume of the MCA superficial territory excluding that in the LSA territory was much greater in SM+L patients than in SM patients.

The initially severe stroke in the SM+L group could be, in part, ascribed to differences in the stroke mechanisms between SM and SM+L. In the present study, the SM+L group more frequently had significant stenosis or occlusion in the MCA or ICA and high-risk PCSE than the SM group. The larger infarction volume in the SM+L group might be associated with those etiologies. The possible mechanisms of superficial MCA territory infarction are embolism from the heart, artery-to-artery embolism from the proximal arterial trees, such as the aorta, carotid artery and MCA, and in-situ thrombosis of the MCA,[@B17][@B18] To produce the concomitant LSA lesion, thrombi from the heart or proximal arteries should be large enough to occlude the MCA trunk or multiple to involve both the superficial MCA and LSA territories.[@B19][@B20] In patients with significant stenosis of the MCA, thromboemboli from the heart or proximal arteries might have been more easily trapped at the MCA trunk to completely occlude the MCA.[@B21] In addition, cardioembolism is known to produce larger infarction and more severe stroke.[@B22][@B23] Finally, the local MCA trunk atheroma could also be the source of the emboli to both the LSA and the superficial MCA branches.

In this study, the presence of LSA territory infarction was an independent predictor of poor long-term outcomes and increased risk of mortality, even after adjustment for the initial NIHSS score and infarction volume. Functional outcome measured by mRS, largely depends on the degree of motor weakness.[@B24] Motor tracts, which pass as compact bundles through the internal capsule,[@B25] could be more frequently damaged in the SM+L group, and this might have caused more severe motor weakness and impeded functional recovery. In patients with large superficial territory infarction, additionally sizable infarctions in the subcortex due to LSA involvement might increase the risk of compressing deep brain structures and brain herniation. In a previous study, patients who had both large artery atherosclerosis and cardioembolism showed very high long-term mortality, while those without showed very low long-term mortality.[@B26] Consistent with the previous findings, the SM+L group more frequently had two or more causes (large artery atherosclerosis and cardioembolism), while the SM group more frequently had undetermined etiology due to negative evaluation.

This study has limitations. First, this study is not free from selection bias because this was a retrospective study, although the cohort data were prospectively and consecutively collected. Second, patients who received reperfusion therapy were excluded from this study. Consequently, some patients with hyperacute MCA infarction were not included in this analysis. Third, the mortality rate of this study is relatively low, compared to the previous studies.[@B27][@B28] We excluded patients with co-existing infarctions in other territories or those with recanalization therapy. These patients might have initially more severe stroke that may be associated with stroke mortality. In addition, cause of death was determined based on medical records or death certificates in some patients. Thus, stroke mortality might not be accurately reflected in some patients. Finally, although the infarction volume in the superficial MCA territory can be influenced by the presence and degree of collateral circulations,[@B20][@B29] they could not be determined because the angiographic studies were not standardized.

In conclusion, among patients with superficial MCA territory infarction, the presence of co-existing LSA territory infarction was associated with initially severe stroke and larger infarct volume in the MCA superficial territory. LSA involvement was almost the most powerful predictor of poor functional outcome and stroke mortality. Therefore, greater concern should be given when treating patients with MCA superficial territory infarction and a co-existing LSA lesion.

This work was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HI08C2149).

The authors have no financial conflicts of interest.

Supplementary Material
======================

###### Supplementary Fig. 1

Patient selection. MCA, middle cerebral artery; DWI, diffusion weighted image.

###### Supplementary Fig. 2

Volume of infarction. Both total volume (45.5±67.3 cm^3^ vs. 10.8±21.8 cm^3^, *p*\<0.001) and superficial MCA territorial volume (40.8±62.6 cm^3^ vs. 10.8±21.8 cm^3^, *p*\<0.001) are significantly larger in the SM+L group. Error bars denote standard deviation of volume. Total infarction volume was the sum of volume for the superficial MCA territory and that for the LSA territory. MCA, middle cerebral artery; LSA, lenticulostriate artery; SM, superficial MCA only; SM+L, superficial MCA plus LSA.

###### Supplementary Table 1

Cox Regression Model in Univariate Analysis

###### Supplementary Table 2

Cox Regression Model of All-Cause Mortality in Multivariate Analysis

![Comparison of mean NIHSS scores for each item between the groups. Scores for all NIHSS items except that for limb ataxia are significantly higher in the SM+L group. NIHSS, National Institute of Health Stroke Scale; SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery; LOC, loss of consciousness.](ymj-58-123-g001){#F1}

![Modified Rankin Scale at 3 months of symptom onset. Numbers are percentages (%). SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery.](ymj-58-123-g002){#F2}

![Kaplan-Meier curve for all-cause mortality (A) and stroke mortality (B). SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery.](ymj-58-123-g003){#F3}

###### Comparison of Baseline Characteristics

![](ymj-58-123-i001)

                                SM (n=314)   SM+L (n=84)   *p* value
  ----------------------------- ------------ ------------- -----------
  Age, yr                       66.5±11.4    68.6±13.0     0.148
  Sex, men                      219 (69.7)   54 (64.3)     0.338
  Hypertension                  222 (70.7)   60 (71.4)     0.896
  Diabetes                      136 (43.3)   34 (40.5)     0.641
  Hypercholesterolemia          45 (14.3)    8 (9.5)       0.249
  Current smoking               82 (26.1)    17 (20.2)     0.268
  Coronary heart disease        74 (23.6)    19 (22.6)     0.855
  Previous medication                                      
   Antiplatelet                 116 (36.9)   25 (29.8)     0.222
   Anticoagulant                23 (7.3)     3 (3.6)       0.216
   Statin                       68 (21.7)    17 (20.2)     0.778
   Antihypertensive             138 (43.9)   43 (51.2)     0.236
   Diabetes medication          25 (8.0)     4 (4.8)       0.316
  Initial NIHSS                 4.02±4.97    10.83±7.11    \<0.001
  Significant brain swelling    10 (3.2)     13 (15.5)     \<0.001
  Laboratory results                                       
   Hemoglobin, g/dL             13.9±2.1     14.2±1.8      0.157
   Hematocrit, %                40.7±5.8     41.9±4.9      0.091
   White blood cells, K/mm^3^   8.0±2.8      9.1±3.2       0.005
   Platelet, K/mm^3^            245.5±84.2   247.9±73.6    0.818
   Prothrombin time, INR        1.0±0.3      1.0±0.2       0.848
   ESR, mm/H                    25.8±23.5    25.9±21.7     0.976
   hsCRP, mg/dL                 11.3±29.5    22.5±50.0     0.057
   Total cholesterol, mmol/L    4.7±1.1      4.6±1.1       0.453
   LDL cholesterol, mmol/L      2.7±0.9      2.8±0.9       0.181
   HDL cholesterol, mmol/L      1.1±0.3      1.1±0.3       0.928
   Fasting sugar, mmol/L        6.6±2.4      6.6±2.1       0.907
   Glycated hemoglobin, %       6.6±1.4      6.6±1.3       0.685

SM, superficial middle cerebral artery only; SM+L, superficial middle cerebral artery plus lenticulostriate artery; NIHSS, National Institutes of Health Stroke Scale; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; hsCRP, high sensitivity C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

Data are number (%), mean±standard deviation.

###### Subtype and Stroke Mechanisms
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                                      SM (n=314)   SM+L (n=84)   *p* value
  ----------------------------------- ------------ ------------- -----------
  Stroke subtype                                                 0.003
   Large artery atherosclerosis^\*^   76 (24.2)    31 (36.9)     
   Cardioembolism                     109 (34.7)   27 (32.1)     
   Two or more causes^\*^             66 (21.0)    22 (26.2)     
   Negative evaluation                63 (20.1)    4 (4.8)       
  Stroke mechanism                                               
   Significant MCA stenosis           43 (13.7)    33 (39.3)     \<0.001
   Significant ICA stenosis           45 (14.3)    28 (33.3)     \<0.001
   High-risk PCSE                     84 (26.8)    35 (41.7)     0.008

SM, superficial MCA only; SM+L, superficial MCA plus lenticulostriate artery; MCA, middle cerebral artery; ICA, internal carotid artery, PCSE, potential cardiac source of embolism.

Values are numbers (%).

^\*^*p*\<0.005; comparison with negative evaluation using Bonferroni post-hoc analysis.

###### Univariate Analysis of Factors Associated with a Poor Outcome at 3 Months

![](ymj-58-123-i003)

                                Patient with favorable outcome (n=294)   Patient with poor outcome (n=104)   *p* value
  ----------------------------- ---------------------------------------- ----------------------------------- -----------
  Age, yr                       65.1±11.6                                72.0±10.6                           \<0.001
  Sex, men                      210 (71.4)                               63 (60.6)                           0.040
  LSA involvement               30 (10.2)                                54 (51.9)                           \<0.001
  Hypertension                  204 (69.4)                               78 (75.0)                           0.279
  Diabetes                      124 (42.3)                               46 (44.2)                           0.716
  Hypercholesterolemia          41 (13.9)                                12 (11.5)                           0.535
  Current smoking               83 (28.2)                                16 (15.4)                           0.009
  Coronary heart disease        71 (24.1)                                22 (21.2)                           0.535
  Initial NIHSS                 3.11±3.73                                12.10±6.76                          \<0.001
  Significant brain swelling    3 (1.0)                                  20 (19.2)                           \<0.001
  Significant MCA stenosis      37 (12.6)                                39 (37.5)                           \<0.001
  Significant ICA stenosis      40 (13.6)                                33 (31.7)                           \<0.001
  High-risk PCSE                71 (24.1)                                48 (46.2)                           \<0.001
  Laboratory results                                                                                         
   Hemoglobin, g/dL             13.9±2.0                                 13.8±2.2                            0.315
   White blood cells, K/mm^3^   7.8±2.6                                  9.3±3.4                             \<0.001
   Platelet, K/mm^3^            245.2±79.1                               248.2±90.2                          0.752
   Prothrombin time, INR        1.0±0.3                                  1.0±0.2                             0.827
   ESR, mm/H                    23.4±21.5                                32.2±26.0                           0.002
   hsCRP, mg/dL                 8.5±22.5                                 28.4±54.8                           0.001
   Total cholesterol, mmol/L    4.7±1.1                                  4.5±1.1                             0.045
   LDL cholesterol, mmol/L      2.7±0.8                                  2.8±1.0                             0.575
   HDL cholesterol, mmol/L      1.1±0.3                                  1.1±0.3                             0.174
   Fasting sugar, mmol/L        6.4±2.4                                  6.9±2.4                             0.121
   Glycated hemoglobin, %       6.6±1.4                                  6.6±1.3                             0.971

LSA, lenticulostriate artery; NIHSS, National Institutes of Health Stroke Scale; MCA, middle cerebra artery; ICA, internal carotid artery; PCSE, potential cardiac source of embolism; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; hsCRP, high sensitivity C-reactive protein; LDL, low-density lipoprotein; HDL, high-density lipoprotein.

Data are number (%), mean±standard deviation.

###### Multivariate Analysis of Factors Associated with a Poor Outcome at 3 Months
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                                                                            Adjusted odds ratio   95% CI          *p* value
  ------------------------------------------------------------------------- --------------------- --------------- -----------
  Age, per increment of 10                                                  2.048                 1.422--2.952    \<0.001
  Sex, men                                                                  0.700                 0.335--1.463    0.343
  Initial NIHSS score                                                       1.203                 1.129--1.292    \<0.001
  Superficial MCA territorial infarction volume, per increment of 1 cm^3^   1.016                 1.002--1.032    0.031
  Significant brain swelling                                                4.903                 0.743--32.362   0.099
  Significant MCA stenosis                                                  2.868                 1.209--6.806    0.017
  Significant ICA stenosis                                                  3.707                 1.617--8.498    0.002
  High-risk PCSE                                                            1.514                 0.702--3.264    0.290
  White blood cells, per increment of 1000                                  1.105                 0.981--1.244    0.101
  Involvement of LSA territory                                              3.686                 1.693--8.027    0.001

NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; ICA, internal carotid artery; PCSE, potential cardiac source of embolism; LSA, lenticulostriate artery; CI, confidence interval.

###### Cox Regression Model of Stroke Mortality in Multivariate Analysis
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                                                                            Model 2                 Model 2                           
  ------------------------------------------------------------------------- ----------------------- --------- ----------------------- -------
  Age, yr, per increment of 10                                              2.114 (1.300--3.537)    0.003     1.983 (1.193--3.297)    0.008
  Sex, men                                                                  3.231 (0.946--11.042)   0.061     2.009 (0.632--6.383)    0.237
  Involvement of LSA territory                                              3.652 (1.071--12.454)   0.038     4.230 (1.394--12.838)   0.011
  Erythrocyte sedimentation rate                                            1.008 (0.998--1.028)    0.431                             
  Initial NIHSS score                                                       1.117 (1.020--1.222)    0.016                             
  Superficial MCA territorial infarction volume, per increment of 1 cm^3^   1.000 (0.990--1.011)    0.958                             
  Significant brain swelling                                                                                  3.302 (1.094--9.961)    0.034
  Significant MCA stenosis                                                                                    3.176 (1.069--9.441)    0.038
  Significant ICA stenosis                                                                                    3.108 (0.992--9.742)    0.052

LSA, lenticulostriate artery; NIHSS, National Institute of Health Stroke Scale; MCA, middle cerebral artery; ICA, internal carotid artery.

Model 1 includes age, sex, erythrocyte sedimentation rate, initial NIHSS, superficial territorial infarction volume and involvement of LSA and model 2 includes age, sex, significant brain swelling, significant MCA stenosis, significant ICA stenosis and involvement of LSA.
